Targeted deletion of Nhe1 gene in GFAP+ reactive astrocytes resulted in reduced endothelial transcytosis, swelling of astrocyte end feet and ECs, structural disruptions of TJs and overall BBB impairment following ischemic stroke in mice. This evidence concerns the gene SLC9A1 and ischemic stroke.